The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law FDA to weigh easing limits on unproven peptides How different peptide therapies may affect your body Prenuvo blog